Insulin therapy and GH-IGF-1 axis disorders in diabetes: Impact of glycaemic control and hepatic insulinization;Insulino-therapie et dysfonctonnements de l'axe GH-IGF-1 au cours du diabete: Impact du controle glycemique et de l'insulinisation hepatique

Diabetes and Metabolism

Volumn 22, Issue 4, 1996, Pages 245-250

  Hanaire Broutin, H ^a   Sallerin Caute, B ^b   Poncet, M F ^a   Tauber, M ^c   Bastide, R ^b   Rosenfeld, R ^d   Tauber, J P ^a  

^a CHU RANGUEIL   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c CHU PURPAN   (France)

^d Purpan University Hospital ^*  (United States)

Author keywords

diabetes; growth hormone binding protein; IGF binding proteins; insulin like growth factor 1; portal insulin

Indexed keywords

GROWTH HORMONE; INSULIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

DIABETES MELLITUS; GROWTH HORMONE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIVER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN DETERMINATION; REVIEW;

BLOOD GLUCOSE; DIABETES MELLITUS; GROWTH HORMONE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; RECEPTORS, SOMATOTROPIN;

EID: 0030054691     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Salardi S, Cacciari E, Ballardini D, et al. Relationships between growth factors (somatomedin-C and growth hormone) and body development, metabolic control and retinal changes in children and adolescents with IDDM. Diabetes, 1986, 35, 832-836.
2. Hansen AP, Johansen K. Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon, and growth hormone in normals and juvenile diabetics. Diabetologia, 1970, 6, 27-33.
3. Zadik Z, Kayne R, Kappy M, Plotnick LP, Kowarski A. Increased integrated concentration of norepinephrine, epinephrine, aldosterone and growth hormone in patients with uncontrolled juvenile diabetes mellitus. Diabetes, 1980, 29, 655-658.
4. Merimee TJ, Fitzgerald CR, Gold LA, McCourt JP. Characteristics of growth hormone secretion in clinically stable diabetes. Diabetes, 1979, 28, 308-312.
5. Schaper NC. Growth hormone secretion in type 1 diabetes : a review. Acta Endocrinol (Copenhagen), 1990, 122, 7-47.
6. Owens DR, Volund A, Jones D, et al. Retinopathy in newly presenting non-insulin-dependent (type 2) diabetic patients. Diabetes Res, 1988, 9, 59-65.
7. Barnes AJ, Kohner EM, Johnston DG, Alberti KGMM. Severe retinopathy and mild carbohydrate intolerance : possible role of insulin deficiency and elevated circulating growth hormone. Lancet, 1985, 1, 1465-1468.
8. Powell DR, Rosenfeld RG, Baker BK, Liu F, Hintz RL. Serum somatomedin levels in adults with chronic renal failure : the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum. J Clin Endocrinol Metab, 1986, 63, 1186-1192.
9. Dills DG, Moss SE, Klein R, Klein BEK, Davis M. Is insulin-like growth factor 1 associated with diabetic retinopathy ? Diabetes, 1990, 39, 191-195.
10. Dills DG, Moss SE, Klein R, Klein BEK. Association of elevated IGF-I levels with increased retinopathy in late onset diabetes. Diabetes, 1991, 40, 1725-1730.
11. Tan K, Baxter RC. Serum insulin-like growth factor I leveels in adult diabetic patients : the effect of age. J Clin Endocrinol Metab, 1986, 63, 651-655.
12. Bach LA, Rechler M. Insulin-like growth factors and diabetes. Diabetes Metab Rev, 1992, 8, 229-257.
13. Leung DW, Spencer SA, Cachianes G, et al. Growth hormone receptor and serum binding protein : purification, cloning and expression. Nature, 1987, 330, 537-543.
14. Menon RK, Arslanian S, May B, Cutfield WS, Sperling MA. Diminished growth hormone-binding protein in children with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 1992, 74, 934-938.
15. Holl RW, Siegler B, Scherbaum WA, Heinze E. The serum growth hormone-binding protein is reduced in young patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 1993, 76, 165-167.
16. Mercado M, Molitch ME, Baumann G. Low plasma growth hormone binding protein in IDDM. Diabetes, 1992, 41, 605-609.
17. Maes M, Ketelslegers JM, Underwood LE. Low plasma somatomedin C in streptozotocin-induced diabetes mellitus : correlation with changes in somatogenic and lactogenic liver binding sites. Diabetes, 1983, 32, 1060-1069.
18. Russell-Jones D, Rattray M, Wilson JV, Jones RH, Sönksen PH, Thomas CR. Intraperitoneal insulin is more potent than subcutaneous insulin at restoring hepatic insulin-like growth factor 1 mRNA levels in the diabetic rat : a functional role for the portal vascular link. J Mol Endocrinol, 1992, 3, 257-263.
19. Maes M, Underwood LE, Ketelslegers JM. Low serum somatomedin C in insulin-dependent diabetes. Endocrinology, 1986, 118, 377-382.
20. Shimasaki S, Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4 and -6). Prog Growth Factor Res, 1992, 3, 243-266.
21. Baxter RC, Martin JL, Beniac VA. High Molecular weight insulin-like growth factor binding protein complexes : purification and protein properties of the acid-labile subunit from human serum. J Biol Chem, 1989, 264, 11843-11848.
22. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocrine Reviews, 1994, 15, 80-101.
23. Brismar K, Gutniak M, Povoa G, Werner S, Hall K. Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. J Endocrinol Invest, 1988, 11, 599-602.
24. Hall K, Brismar K, Grissom F, Lindgren B, Povoa G. IGFBP-1 production and control mechanisms. Acta Endocrinol (Copenhagen), 1991, 124, 48-54.
25. Batch JA, Baxter RC, Werther G. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab, 1991, 73, 964-968.
26. Taylor AM, Dunger DB, Preece MA, et al. The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor I inhibitory bioactivity in adolescent insulin-dependent diabetics. Clin Endocrinol, 1990, 32, 229-239.
27. Cohen P, Fielder PJ, Hasegawa Y, Frisch H, Giudice LC, Rosenfeld RG. Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol, 1991, 124, 74-85.
28. Strasser-Vogel B, Blum WF, Past R, et al. Insulin-like growth factor (IGF)-I and II and IGF-binding proteins-1, -2 and -3 in children and adolescents with diabetes mellitus : correlation with metabolic control and height attainment. J Clin Endocrinol Metab, 1995, 80, 1207-1213.
29. Bereket A, Lang CH, Blethen SL, Fan J, Frost RA, Wilson TA. Insulin-like growth factor protein-3 proteolysis in children with insulin-dependent diabetes mellitus : a possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab, 1995, 80, 2282-2288.
30. Hanaire-Broutin H, Sallerin-Caute B, Poncet MF, et al. Effect of intraperitoneal insulin delivery on growth hormone binding protein, IGF-I and IGFBP-3 in type I diabetic patients, 1996, submitted for publication.
31. Bang P, Brismar K, Rosenfeld RG. Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in non-insulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex. J Clin Endocrinol Metab, 1994, 78, 1119-1127.
32. Sönksen PH, Russell-Jones D, Jones RH. Growth hormone and diabetes mellitus. Horm Res, 1993, 40, 68-79.
33. Arias P, Kerner W, de la Fuente A, Pfeiffer EF. Abnormal growth hormone levels in insulin-dependent diabetic patients under continuous subcutaneous insulin infusion and intensified conventional treatment. Acta Endocrinol, 1984, 107, 250-255.
34. Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press GM, Tambourlane WV. Effects of diabetes and its control on insulin-like growth factors in young subjects with type I diabetes. Diabetes, 1984, 33, 1175-1179.
35. Daughaday WH, Phillips LS, Mueller MC. The effect of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinology, 1976, 98, 1214-1219.
36. Scott CD, Baxter RC. Production of insulin-like growth factor I and its binding protein in rat hepatocytes cultured from diabetic and insulin-treated diabetic rats. Endocrinology, 1986, 119, 2346-2352.
37. Würtzburger MI, Prelevic GM, Sönksen PH, Ljiljana A, Balint-Peric BS, Wheeler M. The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes. J Clin Endocrinol Metab, 1993, 77, 267-272.
38. Arslanian SA, Menon RK, Gierl AP, Heil BV, Foley Jr TP. Insulin therapy increases low plasma growth hormone binding protein in children with new-onset type I diabetes. Diab Med, 1993, 10, 833-838.
39. Gibson JM, Westwood M, Crosby SR, et al. Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab, 1995, 80, 1369-1375.
40. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab, 1994, 79, 872-878.
41. Selam JL, Bergman RN, Raccah D, Jeandidier N, Lozano J, Charles MA. Determination of portal insulin absorption from peritoneum via a novel non-isotopic method. Diabetes, 1990, 39, 1361-1365.
42. Micossi P, Cristallo M, Librenti MC, et al. Free insulin profiles after intraperitoneal, intramuscular, and subcutaneous insulin administration. Diabetes Care, 1986, 9, 575-578.